Stability of refrigerated miglustat after preparation in InOrpha® flavored suspending excipient for compounding of oral solutions and suspensions

Stability of refrigerated miglustat after preparation in InOrpha® flavored suspending excipient for compounding of oral solutions and suspensions

Sofyen Riahi, Michael Ambühl, Jürgen Stichler, Dirk Bandilla Actelion Pharmaceuticals Ltd, Allschwil, Switzerland Background: Miglustat (Zavesca®) is an oral treatment for type 1 Gaucher disease and Niemann–Pick disease type C. Patients with Niemann–Pi...

Full description

Bibliographic Details
Main Authors: Riahi S, Ambühl M, Stichler J, Bandilla D
Format: Article
Language:English
Published: Dove Medical Press 2015-01-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/stability-of-refrigerated-miglustat-after-preparation-in-inorphareg-fl-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/stability-of-refrigerated-miglustat-after-preparation-in-inorphareg-fl-peer-reviewed-article-DDDT

Similar Items